GHSI(SZ:000576)2019-10-29 16:00Financial Performance - Operating revenue for the reporting period was CNY 141,375,027.55, an increase of 41.37% year-on-year[7] - Net profit attributable to shareholders was CNY 60,262,827.53, a significant increase of 4,377.97% compared to the same period last year[7] - Basic earnings per share reached CNY 0.1361, reflecting a growth of 4,352.70% year-on-year[7] - The company reported a net profit excluding non-recurring items of CNY 15,543,439.80, an increase of 1,748.53% year-on-year[7] - The company reported a total profit of ¥65,309,085.74, up from ¥164,165.34 in the previous period[50] - The total comprehensive income for the current period was ¥62,508,293.01, compared to a loss of ¥219,859.19 in the prior period[50] - The company's net profit for Q3 2019 reached CNY 92,913,516.45, a significant recovery from a net loss of CNY 37,297,497.03 in the same period last year, marking a turnaround of over 348%[56] - The operating profit for Q3 2019 was CNY 101,976,420.44, compared to an operating loss of CNY 36,692,846.99 in the previous year, indicating a substantial improvement[56] Cash Flow - The net cash flow from operating activities was CNY -40,248,621.23, representing a decline of 113.26% compared to the previous year[7] - Cash received from operating activities decreased by CNY 261.10 million, a decline of 88.61%, primarily due to the recovery of debts in the previous year[23] - Cash flow from operating activities for the period was CNY 406,062,396.16, compared to CNY 614,669,463.34 in the previous year, indicating a decrease of 34%[63] - The net cash flow from operating activities was -17,218,695.57 yuan, a significant decrease compared to 289,061,272.68 yuan in the previous period[66] - The total cash and cash equivalents at the end of the period were 47,077,941.42 yuan, down from 56,877,138.21 yuan in the previous period[67] Assets and Liabilities - Total assets at the end of the reporting period were CNY 1,631,247,806.97, a decrease of 2.06% compared to the end of the previous year[7] - The company reported a total current assets of CNY 598,296,943.49 as of September 30, 2019, slightly up from CNY 595,963,382.48 at the end of 2018[40] - The total liabilities amounted to CNY 491,459,671.70, compared to CNY 519,428,208.21 previously[42] - The company's equity attributable to shareholders was CNY 1,110,496,533.44, slightly up from CNY 1,109,280,930.94[43] - The total amount of entrusted financial management was CNY 10,000,000, with no overdue amounts reported[33] - Current liabilities totaled CNY 146,186,745.01, down from CNY 267,511,730.03 in the previous period[42] - Long-term borrowings were reported at CNY 94,736,844.00, with total non-current liabilities reaching CNY 345,272,926.69, an increase from CNY 251,916,478.18[42] Shareholder Information - The total number of shareholders at the end of the reporting period was 26,316[12] - The largest shareholder, Delixi Group Co., Ltd., held 41.55% of the shares, with 184,000,000 shares pledged[12] Research and Development - R&D expenses increased by CNY 13.49 million, a significant increase of 1,653.47%, due to the consolidation of Shenyang Energetic and Shenghua Power[21] - Research and development expenses rose to ¥4,894,123.97 from ¥209,759.99, marking an increase of about 2205.5%[49] Investment Activities - Investment income increased by CNY 42.03 million, a substantial increase of 918.76%, mainly from the sale of equity in the biological center and reduced losses from trust products[22] - The company reported investment income of CNY 37,453,740.22 in Q3 2019, a recovery from an investment loss of CNY 4,574,440.61 in the same quarter last year[56] Market Strategy - The company plans to continue expanding its market presence and investing in new technologies to drive future growth[26] - The company plans to continue focusing on market expansion and product development to drive future growth[56]